搜索临床试验以:抗PD-1抗体camrelizumab
总计6971个结果
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国
-
Tongji HospitalWuhan University; Sun Yat-sen University; Wuhan Union Hospital, China暂停
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials Limited招聘中
-
Sixth Affiliated Hospital, Sun Yat-sen University招聘中
-
Shanghai Cell Therapy Research Institute未知
-
Allife Medical Science and Technology Co., Ltd.Beijing Hospital; The First People's Hospital of Yunnan Province/First People's Hospital of... 和其他合作者未知
-
Allife Medical Science and Technology Co., Ltd.Beijing Hospital; Henan Provincial People's Hospital; The First People's Hospital of Yunan Province...未知
-
Shanghai Junshi Bioscience Co., Ltd.未知
-
Shanghai Junshi Bioscience Co., Ltd.未知
-
Buzzard PharmaceuticalsBaylor Research Institute招聘中
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...招聘中
-
Shanghai Jiao Tong University Affiliated Sixth...招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
The First Affiliated Hospital of Soochow University招聘中
-
CellSight Technologies, Inc.Stanford University完全的
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
Tianjin Medical University Cancer Institute and...招聘中
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciences尚未招聘
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciences尚未招聘
-
RenJi Hospital尚未招聘
-
Shandong Cancer Hospital and InstituteBeiGene主动,不招人
-
Beijing Friendship Hospital尚未招聘